ES2184885T3 - Derivados aza-antraciclinona. - Google Patents
Derivados aza-antraciclinona.Info
- Publication number
- ES2184885T3 ES2184885T3 ES96927580T ES96927580T ES2184885T3 ES 2184885 T3 ES2184885 T3 ES 2184885T3 ES 96927580 T ES96927580 T ES 96927580T ES 96927580 T ES96927580 T ES 96927580T ES 2184885 T3 ES2184885 T3 ES 2184885T3
- Authority
- ES
- Spain
- Prior art keywords
- sub
- anthraciclinone
- aza
- derivatives
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 206010002022 amyloidosis Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical class [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
COMPUESTOS DE FORMULA (1) EN DONDE X SUB,1} Y X SUB,2} SON C = O, C = NH O CH SUB,2}, X SUB,3} ES CH SUB,2}, CO, CHOH, DE FORMULA (III), DE FORMULA (IV) EN DONDE N=2 O 3, Y C = N(R SUB,9}) EN DONDE R SUB,9} ES HIDROXI O AMINO-ARILO, Y CADA UNO DE LOS R SUB,1}, R SUB,2}, R SUB,3}, R SUB,4}, R SUB,5}, R SUB,6}, R SUB,7} Y R SUB,8} SON HIDROGENO, HALOGENO O UN RESIDUO ORGANICO, UTILES EN EL TRATAMIENTO DE LA AMILOIDOSIS. TAMBIEN SE DESCRIBE UN PROCESO PARA SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9516349.9A GB9516349D0 (en) | 1995-08-09 | 1995-08-09 | Aza-anthracyclinone derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2184885T3 true ES2184885T3 (es) | 2003-04-16 |
Family
ID=10779013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES96927580T Expired - Lifetime ES2184885T3 (es) | 1995-08-09 | 1996-07-23 | Derivados aza-antraciclinona. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5985887A (es) |
| EP (1) | EP0843675B1 (es) |
| JP (1) | JPH11510500A (es) |
| KR (1) | KR100449580B1 (es) |
| CN (1) | CN1063178C (es) |
| AR (1) | AR010200A1 (es) |
| AT (1) | ATE225347T1 (es) |
| CA (1) | CA2227984C (es) |
| DE (1) | DE69624122T2 (es) |
| DK (1) | DK0843675T3 (es) |
| ES (1) | ES2184885T3 (es) |
| GB (1) | GB9516349D0 (es) |
| IL (1) | IL123000A (es) |
| NO (1) | NO317825B1 (es) |
| NZ (1) | NZ315609A (es) |
| PL (1) | PL185305B1 (es) |
| PT (1) | PT843675E (es) |
| RU (1) | RU2159245C2 (es) |
| TW (1) | TW327170B (es) |
| UA (1) | UA48983C2 (es) |
| WO (1) | WO1997006165A1 (es) |
| ZA (1) | ZA966665B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9701628D0 (en) * | 1997-01-27 | 1997-03-19 | Pharmacia & Upjohn Spa | Imino-aza-anthracyclinone derivatives |
| GB9805082D0 (en) * | 1998-03-10 | 1998-05-06 | Pharmacia & Upjohn Spa | Heterocyclyl anthracyclinone derivatives |
| GB9805080D0 (en) | 1998-03-10 | 1998-05-06 | Pharmacia & Upjohn Spa | Amino anthracyclinone derivatives |
| US7053191B2 (en) * | 2003-05-21 | 2006-05-30 | Solux Corporation | Method of preparing 4-R-substituted 4-demethoxydaunorubicin |
| US8357785B2 (en) * | 2008-01-08 | 2013-01-22 | Solux Corporation | Method of aralkylation of 4′-hydroxyl group of anthracylins |
| US8846882B2 (en) | 2011-04-29 | 2014-09-30 | Synbias Pharma Ag | Method of producing 4-demethoxydaunorubicin |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL110289A (en) * | 1993-08-06 | 1998-01-04 | Policlinico San Matteo Istitut | Pharmaceutical preparations containing 4-iodo-4-deoxydoxorubicin for the treatment of amyloidosis |
| GB9416007D0 (en) * | 1994-08-08 | 1994-09-28 | Erba Carlo Spa | Anthracyclinone derivatives |
| GB9418260D0 (en) * | 1994-09-09 | 1994-10-26 | Erba Carlo Spa | Anthracycline derivatives |
-
1995
- 1995-08-09 GB GBGB9516349.9A patent/GB9516349D0/en active Pending
-
1996
- 1996-07-23 PT PT96927580T patent/PT843675E/pt unknown
- 1996-07-23 RU RU98103795/04A patent/RU2159245C2/ru not_active IP Right Cessation
- 1996-07-23 CN CN96196586A patent/CN1063178C/zh not_active Expired - Fee Related
- 1996-07-23 PL PL96324892A patent/PL185305B1/pl not_active IP Right Cessation
- 1996-07-23 CA CA002227984A patent/CA2227984C/en not_active Expired - Fee Related
- 1996-07-23 NZ NZ315609A patent/NZ315609A/xx unknown
- 1996-07-23 AT AT96927580T patent/ATE225347T1/de not_active IP Right Cessation
- 1996-07-23 DK DK96927580T patent/DK0843675T3/da active
- 1996-07-23 DE DE69624122T patent/DE69624122T2/de not_active Expired - Fee Related
- 1996-07-23 UA UA98031098A patent/UA48983C2/uk unknown
- 1996-07-23 US US09/000,496 patent/US5985887A/en not_active Expired - Fee Related
- 1996-07-23 EP EP96927580A patent/EP0843675B1/en not_active Expired - Lifetime
- 1996-07-23 KR KR10-1998-0700943A patent/KR100449580B1/ko not_active Expired - Fee Related
- 1996-07-23 ES ES96927580T patent/ES2184885T3/es not_active Expired - Lifetime
- 1996-07-23 JP JP9508066A patent/JPH11510500A/ja not_active Withdrawn
- 1996-07-23 WO PCT/EP1996/003237 patent/WO1997006165A1/en not_active Ceased
- 1996-07-23 IL IL12300096A patent/IL123000A/xx not_active IP Right Cessation
- 1996-07-27 TW TW085109190A patent/TW327170B/zh active
- 1996-08-06 ZA ZA966665A patent/ZA966665B/xx unknown
- 1996-08-07 AR ARP960103903A patent/AR010200A1/es active IP Right Grant
-
1998
- 1998-02-06 NO NO19980518A patent/NO317825B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1194646A (zh) | 1998-09-30 |
| NO317825B1 (no) | 2004-12-13 |
| WO1997006165A1 (en) | 1997-02-20 |
| PL324892A1 (en) | 1998-06-22 |
| IL123000A (en) | 2000-10-31 |
| DK0843675T3 (da) | 2003-02-10 |
| DE69624122T2 (de) | 2003-03-20 |
| DE69624122D1 (de) | 2002-11-07 |
| RU2159245C2 (ru) | 2000-11-20 |
| NO980518L (no) | 1998-03-31 |
| US5985887A (en) | 1999-11-16 |
| IL123000A0 (en) | 1998-08-16 |
| AU6735996A (en) | 1997-03-05 |
| KR100449580B1 (ko) | 2004-12-03 |
| JPH11510500A (ja) | 1999-09-14 |
| PL185305B1 (pl) | 2003-04-30 |
| AU712411B2 (en) | 1999-11-04 |
| KR19990036275A (ko) | 1999-05-25 |
| MX9801045A (es) | 1998-10-31 |
| UA48983C2 (uk) | 2002-09-16 |
| AR010200A1 (es) | 2000-06-07 |
| GB9516349D0 (en) | 1995-10-11 |
| NZ315609A (en) | 1999-11-29 |
| EP0843675A1 (en) | 1998-05-27 |
| CA2227984C (en) | 2006-07-11 |
| EP0843675B1 (en) | 2002-10-02 |
| PT843675E (pt) | 2002-12-31 |
| NO980518D0 (no) | 1998-02-06 |
| CN1063178C (zh) | 2001-03-14 |
| ZA966665B (en) | 1997-05-12 |
| TW327170B (en) | 1998-02-21 |
| ATE225347T1 (de) | 2002-10-15 |
| CA2227984A1 (en) | 1997-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2059408T3 (es) | Un proceso para la preparacion de un compuesto. | |
| AR002012A1 (es) | Un compuesto, una composicion farmaceutica que lo comprende, su uso, metodo de tratamiento terapeutico, metodo para la preparacion del compuesto. | |
| ZA988826B (en) | Acylsulfamoylbenzamides crop protection compositions comprising them and processes for their preparation | |
| ATE114316T1 (de) | Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel. | |
| MX9805253A (es) | Antagonistas del receptor de vitronectina. | |
| DE69831937D1 (de) | Bicyclische protein-farnesyl-transferase inhibitoren | |
| HU9301361D0 (en) | Method for producing 4-aryl-piperazines and 4-aryl-piperidines | |
| MX9800411A (es) | Compuestos quimicos. | |
| EA200000592A1 (ru) | Азаполициклические соединения, конденсированные с арилом | |
| BR0211305A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças ou condições e uso de um composto | |
| ES2158452T3 (es) | Uso de agonistas y antagonistas de estrogenos en la fabricacion de un medicamento para el tratamiento de la ateroesclerosis, independientemente de la disminucion de lipidos. | |
| AR007828A1 (es) | Compuestos derivados de piridilpirrol, procedimiento de preparacion y composiciones farmaceuticas conteniendo los mismos | |
| ATE176911T1 (de) | 2'-desoxy-isoguanosine, isostere analoge und isoguanosinderivate sowie deren anwendung | |
| UA41869C2 (uk) | Похідні етаноламіну, спосіб їх одержання, фармацевтична композиція, спосіб лікування | |
| IT1271325B (it) | Composti diastereomericamente puri derivati da 3-oxo e 3-tioxo-4-azaandrostani e loro uso come antiandrogeni | |
| MY107819A (en) | Preparation of substituted piperidines. | |
| ES2177656T3 (es) | Derivados de antraciclinona y su utilizacion en el tratamiento de la amiloidosis. | |
| DK0736029T3 (da) | Antikonvulsive pseudofructopyranosesulfamater | |
| ES2116612T3 (es) | Nuevas bis-naftalimidas para el tratamiento del cancer. | |
| ZA906327B (en) | A method for the treatment of cardiac and of vascular hypertrophy and hyperplasia | |
| ES2134313T3 (es) | Utilizacion de derivados de pregnano para el tratamiento de tumores. | |
| ES2137626T3 (es) | Procedimiento para la preparacion de derivados de ciclopentadienilo. | |
| ES2171553T3 (es) | Derivados de quinoxalina utiles en terapia. | |
| AR010200A1 (es) | Derivados de aza-antraciclinona, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| DK0688212T3 (da) | C9-taxanderivater og farmaceutiske præparater indeholdende disse |